Table 1. Summary of patient baseline characteristics (N = 14).
CharacteristicsStatistics, n (%)
N14
Age at infusion (years)
  Mean (SD)66.9 (8.1)
  Median (range)66 (51–78)
Gender
  Male12 (85)
  Female2 (14)
No. of previous therapies
  Mean (SD)5.3 (2.8)
  Median (range)5 (1–11)
P53 or 17p deletion
  No8 (57)
  Yes6 (43)
IGHV mutation
  No9 (64)
  Yes4 (29)
  Unknown1 (7)
Lymphocyte-depleting chemotherapy
  Bendamustine6 (43)
  Fludarabine/cyclophosphamide3 (21)
  Pentostatin/cyclophosphamide5 (36)
Lymphocytes in bone marrow at enrollment (%)*
  Mean (SD)79.5 (17.9)
  Median (range)87.5 (40–95)
Rai stage
  15 (36)
  49 (64)
Binet stage
  A1 (7)
  B4 (29)
  C9 (64)

*Data not available for four subjects.